Understanding the impact of legislation on 'reduction of disease risk' claims on food and drinks: The REDICLAIM project

The Nutrition and Health Claims Regulation (EC No. 1924/2006) has established a common framework for the regulation of nutrition and health claims used on foods across the European Union. This regulation aims to provide the European food industry opportunities for product innovation whilst protecting consumer interests with respect to controlling misleading advertising and promoting public health. However, in order to satisfy the approval of new health claims procedure particularly for new 'reduction of disease risk' claims [Article 14(1)(a) claims], significant research activity is required by industry to scientifically substantiate the claims they wish to make. There is a need to establish whether the implementation of this legislation is in fact driving product innovation and the development of healthy foods or whether it forms a barrier to such developments. The EU-funded REDICLAIM project is currently considering these issues. This article describes the project's preliminary results and outlines the further programme of work

Where two worlds meet: language policing in mainstream and complementary schools in England

We compare language policing in two educational contexts in England: mainstream schools and complementary schools. We draw on a varied dataset (policy documents, in-class observations, interviews) collected from mainstream schools and Greek complementary schools in London. We find similarities in how the two types of schools control, regulate, monitor and suppress the language of school students. Both settings hierarchise standardised and non-standardised varieties in institutional policies that delegitimise the non-standardised varieties. Teachers become vehicles for language ideologies in enacting monovarietal policies drawing on discourses around academic success and the primacy of written language over spoken language, including regional varieties such as Cypriot Greek. Our findings suggest that multilingual and multidialectal students in England who attend both mainstream and complementary schools are exposed to similar kinds of prescriptive discourses across the whole spectrum of their educational experiences, which can have a range of negative effects on their learning and the construction of their self-image. We argue that more links need to be forged between the two educational settings and that these should include the development of integrated pedagogies and policies that legitimise students’ whole linguistic repertoires, encompassing both their standardised and their non-standardised varieties as well as their other linguistic resources

Exploring the views of infection consultants in England on a novel delinked funding model for antimicrobials: the SMASH study

OBJECTIVES: A novel 'subscription-type' funding model was launched in England in July 2022 for ceftazidime/avibactam and cefiderocol. We explored the views of infection consultants on important aspects of the delinked antimicrobial funding model. METHODS: An online survey was sent to all infection consultants in NHS acute hospitals in England. RESULTS: The response rate was 31.2% (235/753). Most consultants agreed the model is a welcome development (69.8%, 164/235), will improve treatment of drug-resistant infections (68.5%, 161/235) and will stimulate research and development of new antimicrobials (57.9%, 136/235). Consultants disagreed that the model would lead to reduced carbapenem use and reported increased use of cefiderocol post-implementation. The presence of an antimicrobial pharmacy team, requirement for preauthorization by infection specialists, antimicrobial stewardship ward rounds and education of infection specialists were considered the most effective antimicrobial stewardship interventions. Under the new model, 42.1% (99/235) of consultants would use these antimicrobials empirically, if risk factors for antimicrobial resistance were present (previous infection, colonization, treatment failure with carbapenems, ward outbreak, recent admission to a high-prevalence setting).Significantly higher insurance and diversity values were given to model antimicrobials compared with established treatments for carbapenem-resistant infections, while meropenem recorded the highest enablement value. Use of both 'subscription-type' model drugs for a wide range of infection sites was reported. Respondents prioritized ceftazidime/avibactam for infections by bacteria producing OXA-48 and KPC and cefiderocol for those producing MBLs and infections with Stenotrophomonas maltophilia, Acinetobacter spp. and Burkholderia cepacia. CONCLUSIONS: The 'subscription-type' model was viewed favourably by infection consultants in England

Exploring the views of infection consultants in England on a novel delinked funding model for antimicrobials: the SMASH study

OBJECTIVES: A novel ‘subscription-type’ funding model was launched in England in July 2022 for ceftazidime/avibactam and cefiderocol. We explored the views of infection consultants on important aspects of the delinked antimicrobial funding model. METHODS: An online survey was sent to all infection consultants in NHS acute hospitals in England. RESULTS: The response rate was 31.2% (235/753). Most consultants agreed the model is a welcome development (69.8%, 164/235), will improve treatment of drug-resistant infections (68.5%, 161/235) and will stimulate research and development of new antimicrobials (57.9%, 136/235). Consultants disagreed that the model would lead to reduced carbapenem use and reported increased use of cefiderocol post-implementation. The presence of an antimicrobial pharmacy team, requirement for preauthorization by infection specialists, antimicrobial stewardship ward rounds and education of infection specialists were considered the most effective antimicrobial stewardship interventions. Under the new model, 42.1% (99/235) of consultants would use these antimicrobials empirically, if risk factors for antimicrobial resistance were present (previous infection, colonization, treatment failure with carbapenems, ward outbreak, recent admission to a high-prevalence setting). Significantly higher insurance and diversity values were given to model antimicrobials compared with established treatments for carbapenem-resistant infections, while meropenem recorded the highest enablement value. Use of both ‘subscription-type’ model drugs for a wide range of infection sites was reported. Respondents prioritized ceftazidime/avibactam for infections by bacteria producing OXA-48 and KPC and cefiderocol for those producing MBLs and infections with Stenotrophomonas maltophilia, Acinetobacter spp. and Burkholderia cepacia. CONCLUSIONS: The ‘subscription-type’ model was viewed favourably by infection consultants in England

Artificial intelligence in cardiology: Hope for the future and power for the present

Cardiovascular disease (CVD) is the principal cause of mortality and morbidity globally. With the pressures for improved care and translation of the latest medical advances and knowledge to an actionable plan, clinical decision-making for cardiologists is challenging. Artificial Intelligence (AI) is a field in computer science that studies the design of intelligent agents which take the best feasible action in a situation. It incorporates the use of computational algorithms which simulate and perform tasks that traditionally require human intelligence such as problem solving and learning. Whilst medicine is arguably the last to apply AI in its everyday routine, cardiology is at the forefront of AI revolution in the medical field. The development of AI methods for accurate prediction of CVD outcomes, non-invasive diagnosis of coronary artery disease (CAD), detection of malignant arrythmias through wearables, and diagnosis, treatment strategies and prediction of outcomes for heart failure (HF) patients, demonstrates the potential of AI in future cardiology. With the advancements of AI, Internet of Things (IoT) and the promotion of precision medicine, the future of cardiology will be heavily based on these innovative digital technologies. Despite this, ethical dilemmas regarding the implementation of AI technologies in real-world are still unaddressed

Understanding the impact of legislation on ‘reduction of disease risk’ claims on food and drinks: the REDICLAIM project

The Nutrition and Health Claims Regulation (EC No. 1924/2006) has established a common framework for the regulation of nutrition and health claims used on foods across the European Union. This regulation aims to provide the European food industry opportunities for product innovation whilst protecting consumer interests with respect to controlling misleading advertising and promoting public health. However, in order to satisfy the approval of new health claims procedure particularly for new ‘reduction of disease risk’ claims [Article 14(1)(a) claims] , significant research activity is required by industry to scientifically substantiate the claims they wish to make. There is a need to establish whether the implementation of this legislation is in fact driving product innovation and the development of healthy foods or whether it forms a barrier to such developments. The EU-funded REDICLAIM project is currently considering these issues. This article describes the project’s preliminary results and outlines the further programme of work

Stakeholders’ perceptions of precision livestock farming to improve small ruminant welfare

International audienceWithin the TechCare Project, a list of Precision Livestock Farming (PLF) tools, with potential for monitoring animal welfare in small ruminant production, was formulated in TechCare Countries. The opinions of stakeholders weretaken into account after consultations, following a multi-actor approach. The OPERA method was used to reach consensus between stakeholders. Overall, stakeholders’ opinions appear rather uniform. Regarding meat sheep, thehighest appreciated PLF tool was the automated weighing and low frequency identification (LF) system, followed by localisation (GPS) and 3-axial accelerometers, as well as new ultra-high-frequency (UHF) eartags and readers forseveral uses (e.g. water intake). The most suitable PLF tools selected for dairy sheep were environmental-air quality sensors (e.g. weather stations), followed by automated milk recording, LF and automatic weighing. As for dairy goats,in addition to those selected for dairy sheep, the new UHF eartags and readers were prioritized. Regardless of the production system, the most important traits of selected PLF tools were low cost and ease-of-use. Most stakeholdersalso expressed concerns on their ability to collect and handle the data generated from PLF tools for monitoring individual animals. TechCare (www.techcare-project.eu) receives funding from the European Union’s H2020 researchand innovation programme grant no. 862050

Stakeholders’ perceptions of precision livestock farming to improve small ruminant welfare

International audienceWithin the TechCare Project, a list of Precision Livestock Farming (PLF) tools, with potential for monitoring animal welfare in small ruminant production, was formulated in TechCare Countries. The opinions of stakeholders weretaken into account after consultations, following a multi-actor approach. The OPERA method was used to reach consensus between stakeholders. Overall, stakeholders’ opinions appear rather uniform. Regarding meat sheep, thehighest appreciated PLF tool was the automated weighing and low frequency identification (LF) system, followed by localisation (GPS) and 3-axial accelerometers, as well as new ultra-high-frequency (UHF) eartags and readers forseveral uses (e.g. water intake). The most suitable PLF tools selected for dairy sheep were environmental-air quality sensors (e.g. weather stations), followed by automated milk recording, LF and automatic weighing. As for dairy goats,in addition to those selected for dairy sheep, the new UHF eartags and readers were prioritized. Regardless of the production system, the most important traits of selected PLF tools were low cost and ease-of-use. Most stakeholdersalso expressed concerns on their ability to collect and handle the data generated from PLF tools for monitoring individual animals. TechCare (www.techcare-project.eu) receives funding from the European Union’s H2020 researchand innovation programme grant no. 862050

Stakeholders’ perceptions of precision livestock farming to improve small ruminant welfare

International audienceWithin the TechCare Project, a list of Precision Livestock Farming (PLF) tools, with potential for monitoring animal welfare in small ruminant production, was formulated in TechCare Countries. The opinions of stakeholders weretaken into account after consultations, following a multi-actor approach. The OPERA method was used to reach consensus between stakeholders. Overall, stakeholders’ opinions appear rather uniform. Regarding meat sheep, thehighest appreciated PLF tool was the automated weighing and low frequency identification (LF) system, followed by localisation (GPS) and 3-axial accelerometers, as well as new ultra-high-frequency (UHF) eartags and readers forseveral uses (e.g. water intake). The most suitable PLF tools selected for dairy sheep were environmental-air quality sensors (e.g. weather stations), followed by automated milk recording, LF and automatic weighing. As for dairy goats,in addition to those selected for dairy sheep, the new UHF eartags and readers were prioritized. Regardless of the production system, the most important traits of selected PLF tools were low cost and ease-of-use. Most stakeholdersalso expressed concerns on their ability to collect and handle the data generated from PLF tools for monitoring individual animals. TechCare (www.techcare-project.eu) receives funding from the European Union’s H2020 researchand innovation programme grant no. 862050